Literature DB >> 20524092

Antihypertensive effects of aspirin: what is the evidence?

Leonelo E Bautista1, Lina M Vera.   

Abstract

Nonsteroidal anti-inflammatory drugs are known to increase blood pressure and blunt the effect of antihypertensive drugs. Surprisingly, it has been suggested recently that aspirin lowers blood pressure and could be used for preventing hypertension. This review summarizes published data on the effects of aspirin on blood pressure. Trials suggesting that aspirin administered at bedtime lowers blood pressure are uncontrolled, unmasked, and potentially biased. They also conflict with cohort studies showing an 18% increase in the risk of hypertension among aspirin users. Fortunately, short-term use of aspirin does not seem to interfere with antihypertensive drugs. Regardless of its effect on blood pressure, low-dose aspirin effectively prevents cardiovascular events in patients with and without hypertension, but its benefits should be carefully weighed against a potential increase in the risk of adverse effects such as gastric bleeding and hemorrhagic stroke, as well as a small increase in the risk of hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524092     DOI: 10.1007/s11906-010-0115-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Analgesic use and risk of subsequent hypertension in apparently healthy men.

Authors:  Tobias Kurth; Charles H Hennekens; Til Stürmer; Howard D Sesso; Robert J Glynn; Julie E Buring; J Michael Gaziano
Journal:  Arch Intern Med       Date:  2005-09-12

2.  Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Authors:  Jeffrey S Berger; Maria C Roncaglioni; Fausto Avanzini; Ierta Pangrazzi; Gianni Tognoni; David L Brown
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

3.  Nonnarcotic analgesic use and the risk of hypertension in US women.

Authors:  Julien Dedier; Meir J Stampfer; Susan E Hankinson; Walter C Willett; Frank E Speizer; Gary C Curhan
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  Is C-reactive protein an independent risk factor for essential hypertension?

Authors:  L E Bautista; P López-Jaramillo; L M Vera; J P Casas; A P Otero; A I Guaracao
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

5.  Non-narcotic analgesic dose and risk of incident hypertension in US women.

Authors:  John P Forman; Meir J Stampfer; Gary C Curhan
Journal:  Hypertension       Date:  2005-08-15       Impact factor: 10.190

6.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

7.  Aspirin use among adults aged 40 and older in the United States: results of a national survey.

Authors:  Michael Pignone; George K Anderson; Katherine Binns; Hugh H Tilson; Steven M Weisman
Journal:  Am J Prev Med       Date:  2007-05       Impact factor: 5.043

8.  Studies should be controlled, randomized, and blinded.

Authors:  R A Parker
Journal:  Clin Pharmacol Ther       Date:  2009-05       Impact factor: 6.875

9.  Influence of aspirin usage on blood pressure: dose and administration-time dependencies.

Authors:  R C Hermida; J R Fernández; D E Ayala; A Mojón; M Iglesias
Journal:  Chronobiol Int       Date:  1997-11       Impact factor: 2.877

Review 10.  Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials.

Authors:  G A Mansoor; W B White
Journal:  J Cardiovasc Risk       Date:  1994-08
View more
  6 in total

1.  Increases in ambient particulate matter air pollution, acute changes in platelet function, and effect modification by aspirin and omega-3 fatty acids: A panel study.

Authors:  Adan Z Becerra; Steve Georas; J Thomas Brenna; Philip K Hopke; Cathleen Kane; David Chalupa; Mark W Frampton; Robert Block; David Q Rich
Journal:  J Toxicol Environ Health A       Date:  2016-03-30

2.  Clinical Characteristics of Pregnant Women on the Use of Daily Low-dose Aspirin in Different Hypertensive Pregnancy Disorders: A Retrospective Comparative Study.

Authors:  Anmar Al-Taie; Zahraa Albasry; Nadia H Mohammed
Journal:  J Pharm Bioallied Sci       Date:  2019 Jan-Mar

3.  Low-Dose Aspirin Treatment Attenuates Male Rat Salt-Sensitive Hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway.

Authors:  Xiaoliang Jiang; Xue Liu; Xing Liu; Xianxian Wu; Pedro A Jose; Min Liu; Zhiwei Yang
Journal:  J Am Heart Assoc       Date:  2019-12-19       Impact factor: 5.501

4.  Cav 3.2 T-type calcium channel regulates mouse platelet activation and arterial thrombosis.

Authors:  Hem Kumar Tamang; Ruey-Bing Yang; Zong-Han Song; Shao-Chun Hsu; Chien-Chung Peng; Yi-Chung Tung; Bing-Hsiean Tzeng; Chien-Chang Chen
Journal:  J Thromb Haemost       Date:  2022-05-27       Impact factor: 16.036

5.  High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells.

Authors:  Grzegorz Grześk; Marek Kozinski; Udaya S Tantry; Michal Wicinski; Tomasz Fabiszak; Eliano P Navarese; Elzbieta Grzesk; Young-Hoon Jeong; Paul A Gurbel; Jacek Kubica
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

6.  Effects and Mechanisms of Dapagliflozin Treatment on Ambulatory Blood Pressure in Diabetic Patients with Hypertension.

Authors:  Zirao Hao; Yue Sun; Yingzhen Wen; Lijuan Cui; Guiping Li; Yan Liu
Journal:  Med Sci Monit       Date:  2020-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.